Circulating Nucleic Acids Associate with Outcomes of Patients with Pancreatic Cancer

Posted on September 18, 2018 by Gastroenterology Journal

We aimed to investigate the clinical utility of circulating tumor cell DNA (ctDNA) and exosome DNA (exoDNA) in pancreatic cancer.

This entry was posted in News. Bookmark the permalink.